CLP-1 associates with MyoD and HDAC to restore skeletal muscle cell regeneration

Journal of Cell Science

Volumn 123, Issue 21, 2010, Pages 3789-3795

  Galatioto, Josephine ^a   Mascareno, Eduardo ^a   Siddiqui, M A Q ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

CLP 1; HEXIM1; MyoD; P TEFb; Skeletal muscle

Indexed keywords

CARDIAC LINEAGE PROTEIN 1; CELL PROTEIN; CYCLIN D1; ELONGATION FACTOR; HISTONE DEACETYLASE; INHIBITOR PROTEIN; MYOD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; HOMOLOGOUS RECOMBINATION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, BCL-1; HISTONE DEACETYLASES; MICE; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; MYOD PROTEIN; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EUKARYOTA;

EID: 78149327922     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.073387     Document Type: Article

References (30)

1. Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A. and Pestell, R. G. (1995). Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597.
2. Bergstrom, D. A., Penn, B. H., Strand, A., Perry, R. L., Rudnicki, M. A. and Tapscott, S. J. (2002). Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9, 587-600. (Pubitemid 34273789)
3. Cho, S., Schroeder, S., Kaehlcke, K., Kwon, H. S., Pedal, A., Herker, E., Schnoelzer, M. and Ott, M. (2009). Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells. EMBO J. 28, 1407-1417.
4. Espinoza-Derout, J., Wagner, M., Salciccioli, L., Lazar, J. M., Bhaduri, S., Mascareno, E., Chaqour, B. and Siddiqui, M. A. (2009). Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1. Circ. Res. 104, 1347-1354.
5. Fischle, W., Emiliani, S., Hendzel, M. J., Nagase, T., Nomura, N., Voelter, W. and Verdin, E. (1991). A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274, 11713-11720.
6. French, B. A., Chow, K. L., Olson, E. N. and Schwartz, R. J. (1991). Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter. Mol. Cell. Biol. 11, 2439-2450.
7. Fu, J., Yoon, H. G., Qin, J. and Wong, J. (2007). Regulation of P-TEFb elongation complex activity by CDK9 acetylation. Mol. Cell. Biol. 27, 4641-4651. (Pubitemid 47016119)
8. Fu, T. J., Peng, J., Lee, G., Price, D. H. and Flores, O. (1999). Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274, 34527-34530.
9. Huang, F., Wagner, M. and Siddiqui, M. A. (2002). Structure, expression, and functional characterization of the mouse CLP-1 gene. Gene 292, 245-259.
10. Huang, F., Wagner, M. and Siddiqui, M. A. (2004). Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech. Dev. 121, 559-572.
11. Mal, A. and Harter, M. L. (2003). MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. Acad. Sci. USA 100, 1735-1739.
12. Mal, A., Sturniolo, M., Schiltz, R. L., Ghosh, M. K. and Harter, M. L. (2001). A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20, 1739-1753.
13. McKinsey, T. A., Zhang, C. L. and Olson, E. N. (2001). Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11, 497-504.
14. Michels, A. A., Fraldi, A., Li, Q., Adamson, T. E., Bonnet, F., Nguyen, V. T., Sedore, S. C., Price, J. P., Price, D. H., Lania, L. et al. (2004). Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J. 23, 2608-2619.
15. Nguyen, V. T., Kiss, T., Michels, A. A. and Bensaude, O. (2001). 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414, 322-325.
16. Nojima, M., Huang, Y., Tyagi, M., Kao, H. Y. and Fujinaga, K. (2008). The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2. J. Mol. Biol. 382, 275-287.
17. Ogba, N., Chaplin, L. J., Doughman, Y. Q., Fujinaga, K. and Montano, M. M. (2008). HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb. Cancer Res. 68, 7015-7024.
18. Peng, J., Zhu, Y., Milton, J. T. and Price, D. H. (1998). Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755-762.
19. Price, D. H. (2000). P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20, 2629-2634.
20. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. and Levrero, M. (1997). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383. (Pubitemid 27049393)
21. Rudnicki, M. A. and Jaenisch, R. (1995). The MyoD family of transcription factors and skeletal myogenesis. BioEssays 17, 203-209.
22. Sabo, A., Lusic, M., Cereseto, A. and Giacca, M. (2008). Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription. Mol. Cell. Biol. 28, 2201-2212.
23. Sabourin, L. A. and Rudnicki, M. A. (2000). The molecular regulation of myogenesis. Clin. Genet. 57, 16-25.
24. Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. and Kedes, L. (1999). Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4, 725-734.
25. Schulte, A., Czudnochowski, N., Barboric, M., Schonichen, A., Blazek, D., Peterlin, B. M. and Geyer, M. (2005). Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat. J. Biol. Chem. 280, 24968-24977.
26. Simone, C., Stiegler, P., Bagella, L., Pucci, B., Bellan, C., De Falco, G., De Luca, A., Guanti, G. and Puri, P. L. (2002). Activation of MyoD-dependent transcription by cdk9/cyclin T1. Oncogene 21, 4137-4148.
27. Stockdale, F. E. (1992). Myogenic cell lineages. Dev. Biol. 154, 284-298.
28. Yang, Z., Zhu, Q., Luo, K. and Zhou, Q. (2001). The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414, 317-322. (Pubitemid 33097809)
29. Yun, K. and Wold, B. (1996). Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8, 877-889.
30. Zhou, M., Halanski, M. A., Radonovich, M. F., Kashanchi, F., Peng, J., Price, D. H. and Brady, J. N. (2000). Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20, 5077-5086.